Treatment of monostotic fibrous dysplasia with pamidronateKOS, Marcin; LUCZAK, Klaudiusz; GODZINSKI, Jan et al.Journal of cranio-maxillo-facial surgery. 2004, Vol 32, Num 1, pp 10-15, issn 1010-5182, 6 p.Article

Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysisRAUCH, Frank; TRAVERS, Rose; MUNNS, Craig et al.Journal of bone and mineral research (Print). 2004, Vol 19, Num 7, pp 1191-1193, issn 0884-0431, 3 p.Article

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acidKURODA, Junya; KIMURA, Shinya; MAEKAWA, Taira et al.Cancer science. 2004, Vol 95, Num 2, pp 186-192, issn 1347-9032, 7 p.Article

Successful treatment of multicentric reticulohistiocytosis with alendronate: Evidence for a direct effect of bisphosphonate on histiocytesGOTO, Hitoshi; INABA, Masaaki; KOBAYASHI, Keisuke et al.Arthritis and rheumatism. 2003, Vol 48, Num 12, pp 3538-3541, issn 0004-3591, 4 p.Article

Bioequivalence studies on bisphosphonates: The example of alendronateLAINESSE, Audrey; OZALP, Yildiz; HONG WONG et al.Arzneimittel-Forschung. 2004, Vol 54, Num 9A, pp 569-572, issn 0004-4172, 4 p.Article

Bisphosphonates for the treatment of Charcot neuroarthropathyANDERSON, John J; WOELFFER, Kirk E; HOLTZMAN, John J et al.The Journal of foot and ankle surgery. 2004, Vol 43, Num 5, pp 285-289, issn 1067-2516, 5 p.Article

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted TherapyROSSI, A; GRIDELLI, C; RICCIARDI, S et al.Current medicinal chemistry. 2012, Vol 19, Num 32, pp 5524-5535, issn 0929-8673, 12 p.Article

Ion Chromatography Method for Determination of Risedronate in Pharmaceutical PreparationsKANMATAREDDY, Avanthi; DE BORBA, Brian; ROHRER, Jeffrey et al.LC GC North America. 2011, Vol 29, Num SEP, issn 1527-5949, p. 44, SUPArticle

Hydroxybisphosphonate-containing polymeric drug- delivery systems designed for targeting into bone tissueHRUBY, Martin; ETRYCH, Tomas; KUCKA, Jan et al.Journal of applied polymer science. 2006, Vol 101, Num 5, pp 3192-3201, issn 0021-8995, 10 p.Article

Evaluation of multidimensional capillary electrophoretic methodologies for determination of amino bisphosphonate pharmaceuticalsBEXHETI, Dorentina; ANDERSON, Ebo I; HUTT, Andrew J et al.Journal of chromatography. 2006, Vol 1130, Num 1, pp 137-144, issn 0021-9673, 8 p.Conference Paper

Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapyPALOMBA, Stefano; ORIO, Francesco JR; RUSSO, Tiziana et al.Fertility and sterility. 2004, Vol 81, Num 2, pp 476-478, issn 0015-0282, 3 p.Article

Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancerVORDOS, Dimitri; PAULE, Bernard; VACHEROT, Francis et al.BJU international (Papier). 2004, Vol 94, Num 4, pp 524-527, issn 1464-4096, 4 p.Article

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMORRIS, Michael J; SMALETZ, Oren; ZHU, Andrew et al.Cancer. 2004, Vol 100, Num 9, pp 1868-1875, issn 0008-543X, 8 p.Article

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, phase III, double-blind, placebo-controlled trialROSEN, Lee S; GORDON, David; REITSMA, Dirk et al.Cancer. 2004, Vol 100, Num 12, pp 2613-2621, issn 0008-543X, 9 p.Article

Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantationSCHWARZ, Christoph; MITTERBAUER, Christa; HEINZE, Georg et al.Kidney international. 2004, Vol 65, Num 1, pp 304-309, issn 0085-2538, 6 p.Article

Pamidronate in the treatment of childhood SAPHO syndromeKERRISON, C; DAVIDSON, J. E; CLEARY, A. G et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 10, pp 1246-1251, issn 1462-0324, 6 p.Article

Pamidronate-induced nephrotoxic tubular necrosis: a case reportSMETANA, S; MICHLIN, A; ROSENMAN, E et al.Clinical nephrology. 2004, Vol 61, Num 1, pp 63-67, issn 0301-0430, 5 p.Article

Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritisSIMS, Natalie A; GREEN, Jonathan R; GLATT, Markus et al.Arthritis and rheumatism. 2004, Vol 50, Num 7, pp 2338-2346, issn 0004-3591, 9 p.Article

Ostéonécroses de la mâchoire sous diphosphonate = Osteonecrosis of the jaw associated with the use of biphosphonatesLa Revue Prescrire. 2004, Vol 24, Num 256, issn 0247-7750, p. 833Article

Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detections: validation and application in pharmacokinetic studyMUNTONI, E; CANAPARO, R; DELLA PEPA, C et al.Journal of chromatography. B. 2004, Vol 799, Num 1, pp 133-139, issn 1570-0232, 7 p.Article

Stability indicating ion-pair HPLC method for the determination of risedronate in a commercial formulationALUOCH, Austin; TATINI, Radhakrishna; PARSONS, Donald M et al.Journal of liquid chromatography & related technologies. 2004, Vol 27, Num 17, pp 2799-2813, issn 1082-6076, 15 p.Article

Ibandronate in metastatic bone pain : IbandronateHEIDENREICH, Axel; OHLMANN, Carsten; BODY, Jean-Jacques et al.Seminars in oncology. 2004, Vol 31, Num 5, pp 67-72, issn 0093-7754, 6 p., SUP10Article

Head-to-head dimers in the zwitterion of 1-hydroxy-3-(pyrrolidin-1 -yl)-propylidene-1,1-bisphosphonic acid (EB 1053)FERNANDEZ, Daniel; VEGA, Daniel.Acta crystallographica. Section C, Crystal structure communications. 2003, Vol 59, pp o228-o230, issn 0108-2701, 5Article

Zoledronic acid: A review of its use in the management of bone metastases and hypercalcaemia of malignancyWELLINGTON, Keri; GOA, Karen L.Drugs (Basel). 2003, Vol 63, Num 4, pp 417-437, issn 0012-6667, 21 p.Article

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's diseaseRARTRAM, S. A; PEASTON, R. T; RAWLINGS, D. J et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 11-12, pp 1121-1127, issn 0269-2813, 7 p.Article